Indaptus Therapeutics, Inc. (INDP) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q3 EPS of ($0.47), $0.05 better than the analyst estimate of ($0.52).
For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
